
Adherence is a huge problem, for patients, pharmaceutical companies, and the healthcare system as a whole. According to a study released by Capgemini Consulting and HealthPrize, the average lost revenue for all pharma drugs due to non-adherence is a staggering 59%, in other words, billions of dollars in potential revenue. Worse yet, patients who do [...]

